Population
3C proteinase from hepatitis A virus (HAV-3C) and peptide substrates
Design
Preclinical
Authors
Loading...
HAV-3C P'1 preferences defined; leaves open translation to antiviral design pending cellular and in vivo validation.
A rapid screening method using Edman degradation successfully determined the substrate specificity of the HAV-3C proteinase.
Petithory et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: